Shin Aoki

1.6k total citations
46 papers, 1.3k citations indexed

About

Shin Aoki is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Shin Aoki has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Shin Aoki's work include Diabetes Treatment and Management (22 papers), Diabetes Management and Research (13 papers) and Metabolism, Diabetes, and Cancer (10 papers). Shin Aoki is often cited by papers focused on Diabetes Treatment and Management (22 papers), Diabetes Management and Research (13 papers) and Metabolism, Diabetes, and Cancer (10 papers). Shin Aoki collaborates with scholars based in Japan, India and Brazil. Shin Aoki's co-authors include Hidetaka Nakayama, Keimei Mashimo, Koichi Yoshino, Takashi Sasaki, Kenjiro Shinozaki, Satoru Kuwajima, Tomoko Mitsuhashi, Y. Kuroda, Tomohiro Itoh and Shoichi Nakagawa and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Shin Aoki

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shin Aoki Japan	18	726	396	345	209	163	46	1.3k
Noe Gonzales United States	17	383 0.5×	534 1.3×	263 0.8×	143 0.7×	258 1.6×	21	1.2k
Melissa Krauth United States	8	358 0.5×	946 2.4×	197 0.6×	166 0.8×	171 1.0×	8	1.8k
Yuko Izuhara Japan	19	259 0.4×	310 0.8×	468 1.4×	136 0.7×	183 1.1×	33	1.4k
Markus Lassila Finland	21	412 0.6×	490 1.2×	358 1.0×	182 0.9×	189 1.2×	34	1.5k
Angie Goldsberry United States	11	224 0.3×	838 2.1×	124 0.4×	117 0.6×	112 0.7×	26	1.4k
M.R. Jirousek United States	10	219 0.3×	686 1.7×	275 0.8×	97 0.5×	190 1.2×	18	1.4k
P.D. Winocour Canada	20	384 0.5×	268 0.7×	100 0.3×	238 1.1×	119 0.7×	57	1.4k
Teruo Shiba Japan	17	333 0.5×	431 1.1×	162 0.5×	274 1.3×	330 2.0×	47	1.3k
J.C. Fruchart France	18	611 0.8×	867 2.2×	66 0.2×	656 3.1×	289 1.8×	44	1.9k
Gert M. Kostner Austria	31	539 0.7×	501 1.3×	206 0.6×	986 4.7×	413 2.5×	61	2.5k

Countries citing papers authored by Shin Aoki

Since Specialization

Citations

This map shows the geographic impact of Shin Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin Aoki more than expected).

Fields of papers citing papers by Shin Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin Aoki. The network helps show where Shin Aoki may publish in the future.

Co-authorship network of co-authors of Shin Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Shin Aoki. A scholar is included among the top collaborators of Shin Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin Aoki. Shin Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nomoto, Hiroshi, Miki Ito, Hiroyoshi Kurihara, et al.. (2024). Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study). Endocrine Journal. 71(6). 603–616. 9 indexed citations

Nomoto, Hiroshi, Akinobu Nakamura, So Nagai, et al.. (2022). Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study). BMJ Open. 12(5). e056885–e056885. 3 indexed citations

Cho, Kyu Yong, Hiroshi Nomoto, Akinobu Nakamura, et al.. (2021). Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study). Diabetes Research and Clinical Practice. 180. 109069–109069. 4 indexed citations

Miya, Aika, Akinobu Nakamura, Kyu Yong Cho, et al.. (2020). Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin. Journal of Diabetes Investigation. 12(8). 1395–1399. 1 indexed citations

Nomoto, Hiroshi, Akinobu Nakamura, Kyu Yong Cho, et al.. (2020). Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes. Journal of Diabetes Investigation. 12(2). 176–183. 10 indexed citations

Cho, Kyu Yong, Akinobu Nakamura, Kazuno Omori, et al.. (2020). Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone. Journal of Diabetes Investigation. 12(7). 1272–1277. 39 indexed citations

Nomoto, Hiroshi, Kyu Yong Cho, Kazuno Omori, et al.. (2020). Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study. BMJ Open. 10(2). e034883–e034883. 2 indexed citations

Nakamura, Akinobu, Kohei Yamamoto, Hiroshi Nomoto, et al.. (2018). Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial. Journal of Diabetes Investigation. 10(3). 699–705. 29 indexed citations

Takahashi, Kiyohiko, Kyu Yong Cho, Akinobu Nakamura, et al.. (2018). Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation. 10(2). 429–438. 7 indexed citations

10.

Hosoi, Akihiro, Kazuyoshi Takeda, Koji Nagaoka, et al.. (2018). Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy. Scientific Reports. 8(1). 1058–1058. 48 indexed citations

11.

Nomoto, Hiroshi, Hideaki Miyoshi, Tomoo Furumoto, et al.. (2015). A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2). PLoS ONE. 10(8). e0135854–e0135854. 46 indexed citations

12.

Aoki, Shin. (2001). . Journal of Synthetic Organic Chemistry Japan. 59(5). 410–411. 1 indexed citations

13.

Yamaguchi, Yoshiki, Koichi Kato, Mitsuru Shindo, et al.. (1998). Dynamics of the carbohydrate chains attached to the Fc portion of immunoglobulin G as studied by NMR spectroscopy assisted by selective 13C labeling of the glycans. Journal of Biomolecular NMR. 12(3). 385–394. 51 indexed citations

14.

Nakayama, Hidetaka, Shinji Taneda, Tomoko Mitsuhashi, et al.. (1991). Characterization of antibodies to advanced glycosylation end products on protein. Journal of Immunological Methods. 140(1). 119–125. 20 indexed citations

15.

Nakayama, Hidetaka, Shinji Taneda, Satoru Kuwajima, et al.. (1989). Production and characterization of antibodies to advanced glycation products on proteins. Biochemical and Biophysical Research Communications. 162(2). 740–745. 58 indexed citations

16.

Makita, Zenji, et al.. (1988). A radioimmunoassay for an advanced glycosylation endproduct. Journal of Immunological Methods. 112(1). 57–61. 2 indexed citations

17.

Kuroda, Y., et al.. (1987). A significant increase of lysophosphatidylinositol 4‐phosphate with insulin in isolated rat fat cells. FEBS Letters. 224(1). 137–141. 4 indexed citations

18.

Taneda, Shinji, Hidetaka Nakayama, Shin Aoki, et al.. (1986). Radioimmunoassay of Nonenzymatically Glucosylated Albumin. 29(7). 581–590. 1 indexed citations

19.

Nakayama, Hidetaka, Naoki Manda, Shin Aoki, et al.. (1982). Studies on the Determination of Glucosylated Albumin Using Affinity Chromatography. 25(9). 963–968. 1 indexed citations

20.

Nakayama, Hidetaka, Shin Aoki, Naoki Manda, et al.. (1982). Diabetes Mellitus During the Course of Infectious Mononucleosis. 25(5). 625–631. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact